Cargando…

Efficacy of smallpox approved tecovirimat (Tpoxx) drug against Monkeypox: current update and futuristic prospects

Detalles Bibliográficos
Autores principales:	Das, Tuyelee, Nandy, Samapika, Ghosh, Arabinda, Chandran, Deepak, Sharma, Anil K., Dhama, Kuldeep, Dey, Abhijit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389504/ https://www.ncbi.nlm.nih.gov/pubmed/36974695 http://dx.doi.org/10.1097/JS9.0000000000000077

Ejemplares similares

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
por: O’Laughlin, Kevin, et al.
Publicado: (2022)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023)

Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)

Monkeypox clinical symptoms, pathology, and advances in management and treatment options: an update
por: Ahmed, Sirwan K., et al.
Publicado: (2023)

Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023)

Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity
por: Nandy, Samapika, et al.
Publicado: (2020)

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
por: Perzia, Brittany, et al.
Publicado: (2022)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
por: Beatty, Norman L., et al.
Publicado: (2022)

Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight
por: Tudu, Champa Keeya, et al.
Publicado: (2022)

Monkeypox vaccines and vaccination strategies: Current knowledge and advances. An update – Correspondence
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Monkeypox Epidemic: A Throwback From Smallpox Eradication
por: Bethineedi, Lakshmi Deepak, et al.
Publicado: (2022)

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020)

Monkeypox (mpox) in immunosuppressed patients
por: Ahmed, Sirwan Khalid, et al.
Publicado: (2023)

A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
por: Almehmadi, Mazen, et al.
Publicado: (2022)

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
por: Chen, Zhang-Ren, et al.
Publicado: (2022)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

The current emergence of monkeypox: The recurrence of another smallpox?
por: Lu, Tianyu, et al.
Publicado: (2022)

Human monkeypox and smallpox viruses: genomic comparison
por: Shchelkunov, Sergei N., et al.
Publicado: (2001)

Monkeypox outbreak in the post-eradication era of smallpox
por: Kandra, Naga Vishnu, et al.
Publicado: (2023)

Smallpox, Monkeypox and Other Human Orthopoxvirus Infections
por: Shchelkunova, Galina A., et al.
Publicado: (2022)

Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
por: Russo, Andrew T, et al.
Publicado: (2018)

Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination
por: Raccagni, Angelo Roberto, et al.
Publicado: (2022)

Barbaloin: an amazing chemical from the ‘wonder plant’ with multidimensional pharmacological attributes
por: Mitra, Shreya Sikdar, et al.
Publicado: (2022)

A narrative review of pox: smallpox vs monkeypox
por: Jayswal, Samiksha, et al.
Publicado: (2022)

A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome
por: Viguier, Clément, et al.
Publicado: (2022)

Tin-selenide as a futuristic material: properties and applications
por: Kumar, Manoj, et al.
Publicado: (2021)

Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
por: Ali, Yasir, et al.
Publicado: (2023)

COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic
por: Sah, Ranjit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9hmssdbq9p5uga3gk2mjhc5can